<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="carney" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">carney</book-part-id>
      <title-group>
        <title>Carney Complex</title>
        <alt-title alt-title-type="alt-title">Synonym: Carney Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stratakis</surname>
            <given-names>Constantine A</given-names>
          </name>
          <degrees>MD, DSc</degrees>
          <aff>Chief, SEGEN<break/>Scientific Director, NICHD<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>stratakc@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salpea</surname>
            <given-names>Paraskevi</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>NICHD, DEB, SEGEN <break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Raygada</surname>
            <given-names>Margarita</given-names>
          </name>
          <degrees>MSc, PhD</degrees>
          <aff>NICHD, OD<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>5</day>
          <month>2</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>29</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cfc" document-type="chapter">Cardiofaciocutaneous Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cpt1a" document-type="chapter">Carnitine Palmitoyltransferase 1A Deficiency</related-object>
      <abstract id="carney.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Carney complex (CNC) is characterized by skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas. Pale brown to black lentigines are the most common presenting feature of CNC and typically increase in number at puberty. Cardiac myxomas occur at a young age, may occur in any or all cardiac chambers, and manifest as intracardiac obstruction of blood flow, embolic phenomena, and/or heart failure. Other sites for myxomas include the skin, breast, oropharynx, and female genital tract. Primary pigmented nodular adrenocortical disease (PPNAD), which causes Cushing syndrome, is the most frequently observed endocrine tumor in CNC, occurring in approximately 25% of affected individuals. Large-cell calcifying Sertoli cell tumors (LCCSCTs) are observed in one third of affected males within the first decade and in almost all adult males. Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are thyroid follicular adenomas. Clinically evident acromegaly from a growth hormone (GH)-producing adenoma is evident in approximately 10% of adults. Psammomatous melanotic schwannoma (PMS), a rare tumor of the nerve sheath, occurs in an estimated 10% of affected individuals. The median age of diagnosis is 20 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of CNC usually relies on clinical diagnostic criteria. Pathogenic variants in <italic toggle="yes">PRKAR1A</italic> are causative. Sequence analysis of the <italic toggle="yes">PRKAR1A</italic> coding region has a variant detection rate of approximately 60%.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Open-heart surgery for cardiac myxomas; surgical excision of cutaneous and mammary myxomas; bilateral adrenalectomy for Cushing syndrome; transsphenoidal surgery for pituitary adenoma; surgery for cancerous thyroid adenomas; orchiectomy for boys with aggressive LCCSCT and gynecomastia to avoid premature epiphyseal fusion and induction of central precocious puberty (mild gynecomastia can be treated medically); surgery to remove primary and/or metastatic PMS.</p>
          <p>
            <italic toggle="yes">Surveillance:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>For prepubertal children: echocardiography annually or biannually for those with a history of excised myxoma.</p>
            </list-item>
            <list-item>
              <p>For boys with LCCSCT: testicular ultrasound; close monitoring of linear growth rate and annual pubertal staging.</p>
            </list-item>
            <list-item>
              <p>For postpubertal children and adults: echocardiogram annually or biannually for those with a history of excised myxoma; annual testicular ultrasound; baseline thyroid ultrasound with repeat as necessary; baseline transabdominal ultrasound of the ovaries with repeat as necessary; annual urinary free cortisol levels; and annual serum IGF-1 levels.</p>
            </list-item>
          </list>
          <p>Further evaluation in all age groups may include: diurnal cortisol levels, dexamethasome stimulation test, and adrenal computed tomography for primary pigmented nodular adrenocortical disease; pituitary MRI, 3-hour oral glucose tolerance test, and 90-minute thyroid releasing hormone testing for gigantism/acromegaly; MRI (brain, spine, chest, abdomen, retroperitoneum, pelvis) for psammamotous melanotic schwannoma.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> When the family-specific pathogenic variant is known, molecular genetic testing to clarify the genetic status of at-risk family members so that appropriate evaluation and surveillance can enable early diagnosis of treatable manifestations.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>CNC is inherited in an autosomal dominant manner. Approximately 70% of individuals diagnosed with CNC have an affected parent; approximately 30% have a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with CNC has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="carney.Diagnosis">
        <title>Diagnosis</title>
        <sec id="carney.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of Carney complex (CNC) <bold>should be suspected</bold> in individuals with the following features; a definite diagnosis is given when <bold>two or more major manifestations</bold> are present:</p>
          <p>
            <bold>Major diagnostic criteria for CNC</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Spotty skin pigmentation with typical distribution (lips, conjunctiva and inner or outer canthi, vaginal and penile mucosal)</p>
            </list-item>
            <list-item>
              <p>Myxoma* (cutaneous and mucosal)</p>
            </list-item>
            <list-item>
              <p>Cardiac myxoma*</p>
            </list-item>
            <list-item>
              <p>Breast myxomatosis* or fat-suppressed MRI findings suggestive of this diagnosis</p>
            </list-item>
            <list-item>
              <p>Primary pigmented nodular adrenocortical disease (PPNAD)* or paradoxical positive response of urinary glucocorticosteroid excretion to dexamethasone administration during Liddle's test</p>
            </list-item>
            <list-item>
              <p>Acromegaly as a result of growth hormone (GH)-producing adenoma*</p>
            </list-item>
            <list-item>
              <p>Large-cell calcifying Sertoli cell tumor (LCCSCT)* or characteristic calcification on testicular ultrasound</p>
            </list-item>
            <list-item>
              <p>Thyroid carcinoma* or multiple, hypoechoic nodules on thyroid ultrasound in a child younger than age 18 years</p>
            </list-item>
            <list-item>
              <p>Psammomatous melanotic schwannomas (PMS)*</p>
            </list-item>
            <list-item>
              <p>Blue nevus, epithelioid blue nevus*</p>
            </list-item>
            <list-item>
              <p>Breast ductal adenoma*</p>
            </list-item>
            <list-item>
              <p>Osteochondromyxoma*</p>
            </list-item>
          </list>
          <p>Note: * denotes after histologic confirmation [<xref ref-type="bibr" rid="carney.REF.mateus.2008.801">Mateus et al 2008</xref>]</p>
          <p>
            <bold>Supplementary criteria</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Affected first-degree relative</p>
            </list-item>
            <list-item>
              <p>Inactivating pathogenic variant in <italic toggle="yes">PRKAR1A</italic></p>
            </list-item>
          </list>
          <p>
            <bold>Findings suggestive of or possibly associated with CNC, but not diagnostic for the disease</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Intense freckling (without darkly pigmented spots or typical distribution)</p>
            </list-item>
            <list-item>
              <p>Blue nevus, common type (if multiple)</p>
            </list-item>
            <list-item>
              <p>Caf&#x000e9;-au-lait spots or other &#x02018;birthmarks&#x02019;</p>
            </list-item>
            <list-item>
              <p>Elevated IGF-I levels, abnormal glucose tolerance test (GTT), or paradoxical GH response to TRH (thyrotropin-releasing hormone) testing in the absence of clinical acromegaly</p>
            </list-item>
            <list-item>
              <p>Cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Pilonidal sinus</p>
            </list-item>
            <list-item>
              <p>History of Cushing's syndrome, acromegaly, or sudden death in extended family</p>
            </list-item>
            <list-item>
              <p>Multiple skin tags or other skin lesions; lipomas</p>
            </list-item>
            <list-item>
              <p>Colonic polyps (usually in association with acromegaly)</p>
            </list-item>
            <list-item>
              <p>Hyperprolactinemia (usually mild and almost always combined with clinical or subclinical acromegaly)</p>
            </list-item>
            <list-item>
              <p>Single, benign thyroid nodule in a child younger than age 18 years; multiple thyroid nodules in an individual older than age 18 years (detected on ultrasound examination)</p>
            </list-item>
            <list-item>
              <p>Family history of carcinoma, in particular of the thyroid, colon, pancreas, and ovary; other multiple benign or malignant tumors</p>
            </list-item>
          </list>
          <p>Criteria reprinted from <xref ref-type="bibr" rid="carney.REF.mateus.2008.801">Mateus et al [2008]</xref> with permission of Elsevier Publishing</p>
        </sec>
        <sec id="carney.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of CNC <bold>is established</bold> in a proband with two or more major clinical manifestations (see <xref ref-type="sec" rid="carney.Suggestive_Findings">Suggestive Findings</xref>) and/or when a pathogenic variant is identified in <italic toggle="yes">PRKAR1A</italic> (see <xref ref-type="table" rid="carney.T.summary_of_molecular_genetic_te">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">PRKAR1A</italic> is performed first, followed by deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">PRKAR1A</italic> and other genes of interest (see <xref ref-type="sec" rid="carney.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, or mitochondrial sequencing may be considered if single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">PRKAR1A</italic>) fails to confirm a diagnosis in an individual with features of CNC. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="carney.T.summary_of_molecular_genetic_te" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Carney Complex</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">PRKAR1A</italic>
                  </td>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">60%&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~10%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6,&#x000a0;7,&#x000a0;8</sup></td>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_carney.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>NA= not applicable</p>
              </fn>
              <fn id="carney.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="carney" object-id="carney.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="carney.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="carney.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="carney.TF.1.3">
                <label>3. </label>
                <p>In the largest study to date, 114 (62%) of 185 families studied had an identifiable <italic toggle="yes">PRKAR1A</italic> pathogenic variant [<xref ref-type="bibr" rid="carney.REF.bertherat.2009.2085">Bertherat et al 2009</xref>]. The variant detection frequency increases to 80% in individuals with CNC presenting with Cushing syndrome caused by PPNAD [<xref ref-type="bibr" rid="carney.REF.cazabat.2007.1">Cazabat et al 2007</xref>].</p>
              </fn>
              <fn id="carney.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="carney.TF.1.5">
                <label>5. </label>
                <p>In a study of 36 unrelated individuals with CNC who were negative for <italic toggle="yes">PRKAR1A</italic> single nucleotide variants, two large <italic toggle="yes">PRKAR1A</italic> deletions were identified [<xref ref-type="bibr" rid="carney.REF.horvath.2008.388">Horvath et al 2008</xref>]. Recent study revealed that 21.6% (51 tested) of individuals with CNC who were negative for other <italic toggle="yes">PRKAR1A</italic> pathogenic variants were positive for <italic toggle="yes">PRKAR1A</italic> deletions [<xref ref-type="bibr" rid="carney.REF.salpea.2014.e183">Salpea et al 2014</xref>] (see <xref ref-type="table" rid="carney.T.prkar1a_pathogenic_variants_dis">Table 2</xref>). The deletions ranged from 328 bp to 3 Mb affecting part or all of <italic toggle="yes">PRKAR1A</italic> and in all cases leading to <italic toggle="yes">PRKAR1A</italic> haploinsufficiency.</p>
              </fn>
              <fn id="carney.TF.1.6">
                <label>6. </label>
                <p>Approximately 20% of families with CNC have been linked to 2p16 [<xref ref-type="bibr" rid="carney.REF.stratakis.1996.699">Stratakis et al 1996</xref>].</p>
              </fn>
              <fn id="carney.TF.1.7">
                <label>7. </label>
                <p><italic toggle="yes">PRKACA</italic> pathogenic germline gene duplication has been detected in five individuals(4 kindreds) with CNC who have adrenal tumors and Cushing syndrome (&#x0003c;1% of CNC affected families) [<xref ref-type="bibr" rid="carney.REF.beuschlein.2014.1019">Beuschlein et al 2014</xref>]. In one of these kindreds, the variant was inherited, as both mother and son were carriers; in another individual, the amplification was <italic toggle="yes">de novo</italic>, as neither parent was a carrier [<xref ref-type="bibr" rid="carney.REF.beuschlein.2014.1019">Beuschlein et al 2014</xref>].</p>
              </fn>
              <fn id="carney.TF.1.8">
                <label>8. </label>
                <p>One individual with CNC (&#x0003c;1% of CNC affected families) had a germline rearrangement resulting in four copies of <italic toggle="yes">PRKACB</italic> [<xref ref-type="bibr" rid="carney.REF.forlino.2014.1065">Forlino et al 2014</xref>]. <italic toggle="yes">PRKACB</italic> encodes the catalytic subunit C&#x003b2; of the cyclic AMP-dependent protein kinase A (PKA). Levels of C&#x003b2; and PKA activity were increased in the individual&#x02019;s lymphoblasts and fibroblasts; the authors propose that this is a CNC-causing gain-of-function variant.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="carney.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="carney.Clinical_Description">
          <title>Clinical Description</title>
          <p>The Carney complex (CNC) of skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas may be evident at birth, although the median age of diagnosis is 20 years.</p>
          <p>
            <bold>Skin pigment abnormalities</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Pale brown to black lentigines are the most common presenting feature of CNC and may be present at birth. Typically, they increase in number and appear anywhere on the body including the face, the lips, and mucosa around puberty. These lentigines tend to fade after the fourth decade, but may still be evident in the eighth decade.</p>
            </list-item>
            <list-item>
              <p>Additional pigmentary abnormalities that develop over time are epithelioid-type blue nevi (small bluish domed papules with a smooth surface), combined nevi, caf&#x000e9; au lait spots, and depigmented lesions.</p>
            </list-item>
          </list>
          <p>
            <bold>Myxomas</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Cutaneous myxomas are papules or subcutaneous nodules that usually have a smooth surface and are white, flesh-colored, opalescent, or pink. They appear between birth and the fourth decade. Most individuals with CNC have multiple lesions. Myxomas occur on any part of the body except the hands and feet and typically affect the eyelids, external ear canal, and nipples.</p>
            </list-item>
            <list-item>
              <p>Cardiac myxomas occur at a young age and may occur in any or all cardiac chambers. Cardiac myxomas present with symptoms related to intracardiac obstruction of blood flow, embolic phenomenona (into the systemic circulation), and/or heart failure. Myxomas that completely occlude a valvular orifice can cause sudden death.</p>
            </list-item>
            <list-item>
              <p>Breast myxomas, often bilateral, occur in females after puberty. Both males and females may develop breast nipple myxomas at any age.</p>
            </list-item>
            <list-item>
              <p>Other sites for myxomas include the oropharynx (tongue, hard palate, pharynx) and the female genital tract (uterus, cervix, vagina).</p>
            </list-item>
            <list-item>
              <p>Osteochondromyxoma is a rare myxomatous tumor of the bone that affects nasal sinuses and long bones.</p>
            </list-item>
          </list>
          <p>
            <bold>Endocrine tumors</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Primary pigmented nodular adrenocortical disease (PPNAD)</bold> is associated with adrenocorticotropic hormone (ACTH)-independent overproduction of cortisol (hypercortisolism). PPNAD is the most frequently observed endocrine tumor in individuals with CNC, occurring in an estimated 25% of affected individuals. Among those with a <italic toggle="yes">PRKAR1A</italic> pathogenic variant, Cushing syndrome caused by PPNAD is seen in 70% of affected females before age 45 years but in only 45% of affected males, likely reflecting the generally higher frequency of Cushing syndrome in females. Histologic evidence of PPNAD has been found in almost every individual with CNC undergoing autopsy.</p>
              <p>Symptomatic individuals have Cushing syndrome. The hypercortisolism of PPNAD is usually insidious in onset. In children, hypercortisolism is manifest first as weight gain and growth arrest. In adults, longstanding hypercortisolism results in central obesity, "moon facies," hirsutism, striae, hypertension, buffalo hump fat distribution, weakness, easy bruising, and psychological disturbance. In a minority of individuals, PPNAD presents in the first two to three years; in the majority it presents in the second or third decade.</p>
            </list-item>
            <list-item>
              <p><bold>GH-producing adenoma.</bold> Clinically evident acromegaly is a relatively frequent manifestation of CNC, occurring in approximately 10% of adults at the time of presentation. Gigantism, resulting from excess GH secretion prior to puberty, is rare. However, asymptomatic increased serum concentration of GH and insulin-like growth factor type-1 (IGF-1), as well as subtle hyperprolactinemia, may be present in up to 75% of individuals with CNC. Somatomammotroph hyperplasia, a putative precursor of GH-producing adenoma, may explain the protracted period of onset of clinical acromegaly in individuals with CNC.</p>
            </list-item>
            <list-item>
              <p><bold>Testicular tumors.</bold> Large-cell calcifying Sertoli cell tumors (LCCSCT) are observed in one third of affected males at the time of presentation, which is often within the first decade. Most adult males with CNC have evidence of LCCSCT. The tumors are often multicentric and bilateral. LCCSCT is almost always benign; malignancy has been reported only once, in a 62-year-old. LCCSCT may be hormone producing; gynecomastia in prepubertal and peripubertal boys may result from increased P-450 aromatase expression. Other testicular tumors observed in individuals with LCCSCT include Leydig cell tumors and (pigmented nodular) adrenocortical rest tumors.</p>
            </list-item>
            <list-item>
              <p><bold>Thyroid adenoma or carcinoma.</bold> Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are nonfunctioning thyroid follicular adenomas. Thyroid carcinomas, both papillary and follicular, can occur and occasionally may develop in a person with a long history of multiple thyroid adenomas.</p>
            </list-item>
          </list>
          <p>
            <bold>Schwannomas</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Psammomatous melanotic schwannoma (PMS).</bold> This rare tumor of the nerve sheath occurs in approximately 10% of individuals with CNC. Malignant degeneration occurs in approximately 10% of those with CNC [<xref ref-type="bibr" rid="carney.REF.watson.2000.413">Watson et al 2000</xref>]. PMS may occur anywhere in the central and peripheral nervous system; it is most frequently found in the nerves of the gastrointestinal tract (esophagus and stomach) and paraspinal sympathetic chain (28%). The spinal tumors present as pain and radiculopathy in adults (mean age 32 years).</p>
            </list-item>
          </list>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Breast ductal adenoma</bold> is a benign tumor of the mammary gland ducts.</p>
            </list-item>
          </list>
          <p><bold>Life span.</bold> Most individuals with CNC have a normal life span. However, because some die at an early age, the average life expectancy for individuals with CNC is 50 years. Causes of death include complications of cardiac myxoma (myxoma emboli, cardiomyopathy, cardiac arrhythmia, surgical intervention), metastatic or intracranial PMS, thyroid carcinoma, and metastatic pancreatic and testicular tumors.</p>
          <p><bold>Fertility.</bold> LCCSCT causes replacement and obstruction of seminiferous tubules, macroorchidism, oligoasthenospermia, and inappropriate hormone production or aromatization. Despite these findings, fertility is frequently preserved.</p>
        </sec>
        <sec id="carney.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Clinical and genotypic data on more than 380 affected individuals are available from more than 20 years of study at the National Institutes of Health (Bethesda, MD) and the Hospital C&#x000f4;chin (Paris). Phenotype analysis in 353 individuals with 80 different <italic toggle="yes">PRKAR1A</italic> pathogenic variants is summarized [<xref ref-type="bibr" rid="carney.REF.bertherat.2009.2085">Bertherat et al 2009</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>A <italic toggle="yes">PRKAR1A</italic> pathogenic variant was seen more often in individuals with the combination of myxomas (affecting multiple locations such as skin, heart, and breast), psammomatous melanotic schwannomas (PMS), thyroid tumors, and large-cell calcifying Sertoli cell tumor (LCCSCT) than in individuals with CNC without this combination of findings.</p>
            </list-item>
            <list-item>
              <p>The &#x02018;&#x02018;hot spot&#x02019;&#x02019; pathogenic variant, <xref ref-type="table" rid="carney.T.prkar1a_pathogenic_variants_dis">c.491_492delTG</xref>, was more likely to be associated with lentigines, cardiac myxoma, and thyroid tumors than all other <italic toggle="yes">PRKAR1A</italic> pathogenic variants combined.</p>
            </list-item>
            <list-item>
              <p>Individuals with CNC heterozygous for a <italic toggle="yes">PRKAR1A</italic> pathogenic variant presented more frequently and earlier in life with pigmented skin lesions, myxomas, thyroid tumors, and gonadal tumors than those without an identifiable pathogenic variant. Tumors that presented at a significantly younger age in <italic toggle="yes">PRKAR1A</italic> heterozygotes than in individuals with CNC without an identifiable pathogenic variant included cardiac myxomas, thyroid tumors, and LCCSCTs.</p>
            </list-item>
            <list-item>
              <p>Those with isolated primary pigmented nodular adrenocortical disease (PPNAD) (which was in some cases accompanied by lentiginosis) diagnosed before age eight years were rarely heterozygous for a <italic toggle="yes">PRKAR1A</italic> pathogenic variant. The two <italic toggle="yes">PRKAR1A</italic> pathogenic variants commonly seen in those with isolated PPNAD were <xref ref-type="table" rid="carney.T.prkar1a_pathogenic_variants_dis">c.709-2_709-7 delATTTTT</xref> and <xref ref-type="table" rid="carney.T.prkar1a_pathogenic_variants_dis">c.1A&#x0003e;G</xref> substitution affecting the initiation codon of the protein.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">PRKAR1A</italic> exon variants were associated more frequently with lentigines, PMS, acromegaly, and cardiac myxomas than were intron variants, consistent with the observation that milder phenotypes are more likely to be associated with splice variants than other types of pathogenic variants.</p>
            </list-item>
            <list-item>
              <p>Large <italic toggle="yes">PRKAR1A</italic> deletions (328 bp to 3 Mb) were found to lead to a phenotype that varied but was generally severe and unusual, presumably as a result of haploinsufficiency of additional genes [<xref ref-type="bibr" rid="carney.REF.salpea.2014.e183">Salpea et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="carney.Penetrance">
          <title>Penetrance</title>
          <p>The overall penetrance of CNC in those with a <italic toggle="yes">PRKAR1A</italic> pathogenic variant is greater than 95% by age 50 years.</p>
          <p>Thus far only two <italic toggle="yes">PRKAR1A</italic> pathogenic variants are known to result in incomplete penetrance of CNC: the splice variant c.709-7_709-2del and the initiation-alternating substitution <xref ref-type="table" rid="carney.T.prkar1a_pathogenic_variants_dis">p.Met1Val</xref>. When expressed, these two pathogenic variants lead to relatively mild CNC, manifest mostly as PPNAD, which can be accompanied by lentigines [<xref ref-type="bibr" rid="carney.REF.groussin.2006.1943">Groussin et al 2006</xref>].</p>
        </sec>
        <sec id="carney.Nomenclature">
          <title>Nomenclature</title>
          <p>Carney complex has also been designated by the following acronyms:</p>
          <list list-type="bullet">
            <list-item>
              <p>NAME (<italic toggle="yes">n</italic>evi, <italic toggle="yes">a</italic>trial <italic toggle="yes">m</italic>yxomas, <italic toggle="yes">e</italic>phelides)</p>
            </list-item>
            <list-item>
              <p>LAMB (<italic toggle="yes">l</italic>entigines, <italic toggle="yes">a</italic>trial <italic toggle="yes">m</italic>yxoma, <italic toggle="yes">b</italic>lue nevi)</p>
            </list-item>
          </list>
          <p><bold>"Carney triad"</bold> is a completely different entity consisting of a triad of gastrointestinal stromal tumors, pulmonary chondroma, and extra-adrenal paraganglioma.</p>
        </sec>
        <sec id="carney.Prevalence">
          <title>Prevalence</title>
          <p>More than 700 individuals with CNC are known to the authors. These include whites, African Americans, and Asians, from North and South America, Europe, Australia, and Asia.</p>
        </sec>
      </sec>
      <sec id="carney.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>The following phenotypes are also associated with germline mutation of <italic toggle="yes">PRKAR1A</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sporadic isolated (not CNC-associated) primary pigmented nodular adrenocortical disease (PPNAD) [<xref ref-type="bibr" rid="carney.REF.groussin.2002.1433">Groussin et al 2002</xref>]</p>
          </list-item>
          <list-item>
            <p>Sporadic undifferentiated thyroid cancers and sporadic papillary thyroid cancers [<xref ref-type="bibr" rid="carney.REF.sandrini.2002b.182">Sandrini et al 2002b</xref>]</p>
          </list-item>
          <list-item>
            <p>Adrenal tumors [<xref ref-type="bibr" rid="carney.REF.bertherat.2003.5308">Bertherat et al 2003</xref>]</p>
          </list-item>
        </list>
        <p>Sporadic tumors (including odontogenic myxomas, occurring as single tumors in the absence of any other findings of this syndrome) have been associated with somatic variants in <italic toggle="yes">PRKAR1A</italic> that are <bold>not</bold> present in the germline [<xref ref-type="bibr" rid="carney.REF.perdig_o.2005.204">Perdig&#x000e3;o et al 2005</xref>]; thus, predisposition to these tumors is not heritable. For more details see <xref ref-type="sec" rid="carney.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</xref>.</p>
      </sec>
      <sec id="carney.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Skin.</bold> Disorders in which lentigines occur include benign familial lentiginosis (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/151001">151001</ext-link>), <related-object link-type="booklink" source-id="gene" document-id="pjs" document-type="chapter">Peutz-Jeghers syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="leopard" document-type="chapter">LEOPARD syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="noonan" document-type="chapter">Noonan syndrome</related-object> with lentiginosis, and the Bannayan-Riley-Ruvalcaba syndrome, which is one of the phenotypes observed in the <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartoma tumor syndrome</related-object>. The caf&#x000e9; au lait spots of Carney complex (CNC) can resemble those of McCune-Albright syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/174800">174800</ext-link>), <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis type 1</related-object>, <related-object link-type="booklink" source-id="gene" document-id="nf2" document-type="chapter">neurofibromatosis type 2</related-object>, and Watson syndrome (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/193520">193520</ext-link>). Epithelioid blue nevi may occur as solitary lesions in individuals who have no findings to suggest CNC.</p>
        <p><bold>Cardiac myxoma.</bold> Cardiac myxoma is the most common type of cardiac tumor in adults and accounts for approximately 30% of cardiac tumors in children. Genetic studies reveal no apparent association between CNC and sporadic myxomas [<xref ref-type="bibr" rid="carney.REF.fogt.2002.59">Fogt et al 2002</xref>].</p>
        <p>Kindreds have been described with familial myxomas, CNC, and cardiomyopathy associated with a single pathogenic variant of a protein that belongs to the family of myosins [<xref ref-type="bibr" rid="carney.REF.veugelers.2004.460">Veugelers et al 2004</xref>]. This condition is distinct from CNC and is either a separate disorder or the concurrence of two genetic disorders in one family [<xref ref-type="bibr" rid="carney.REF.stratakis.2004.2556">Stratakis et al 2004</xref>].</p>
        <p><bold>Endocrine tumors.</bold> Thyroid tumors also occur in Cowden syndrome, one of the phenotypes observed in the <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartoma tumor syndrome</related-object>. Rarely, sporadic thyroid tumors may harbor somatic <italic toggle="yes">PRKAR1A</italic> pathogenic variants [<xref ref-type="bibr" rid="carney.REF.sandrini.2002b.182">Sandrini et al 2002b</xref>].</p>
        <p>Large-cell calcifying Sertoli cell tumor (LCCSCT) is also seen in <related-object link-type="booklink" source-id="gene" document-id="pjs" document-type="chapter">Peutz-Jeghers syndrome</related-object>, in which the tumor may also be hormone producing. Ovarian tumors similar to those seen in Peutz-Jeghers syndrome are not observed in CNC [<xref ref-type="bibr" rid="carney.REF.stratakis.2000.4359">Stratakis et al 2000</xref>].</p>
        <p>CNC accounts for approximately 80% of bilateral micronodular adrenal hyperplasia; sporadic isolated (not CNC-associated) primary pigmented nodular adrenocortical disease (PPNAD) can also be caused by pathogenic variants in <italic toggle="yes">PRKAR1A</italic> [<xref ref-type="bibr" rid="carney.REF.groussin.2002.1433">Groussin et al 2002</xref>]. Isolated micronodular adrenocortical hyperplasia may be associated with inactivating pathogenic variants in <italic toggle="yes">PDE11A</italic>, the gene encoding dual-specificity phosphodiesterase [<xref ref-type="bibr" rid="carney.REF.horvath.2006.794">Horvath et al 2006</xref>].</p>
        <p>Adrenal cortical tumors are also seen in <related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter">Beckwith-Wiedemann syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="li-fraumeni" document-type="chapter">Li-Fraumeni syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="men1" document-type="chapter">multiple endocrine neoplasia type 1</related-object>, congenital adrenal hyperplasia resulting from <related-object link-type="booklink" source-id="gene" document-id="cah" document-type="chapter">21-hydroxylase deficiency</related-object>, and the <related-object link-type="booklink" source-id="gene" document-id="mccune-albright" document-type="chapter">McCune-Albright syndrome</related-object> [<xref ref-type="bibr" rid="carney.REF.kjellman.2001.948">Kjellman et al 2001</xref>].</p>
        <p>GH-secreting pituitary adenomas (somatotropinomas) can also be seen in <related-object link-type="booklink" source-id="gene" document-id="men1" document-type="chapter">multiple endocrine neoplasia type 1</related-object> (MEN1) or isolated familial somatotropinomas (IFS), which maps to 11q13.1-q13.3 or 2p16 [<xref ref-type="bibr" rid="carney.REF.stratakis.2000.4920">Stratakis &#x00026; Kirschner 2000</xref>, <xref ref-type="bibr" rid="carney.REF.frohman.2003.165">Frohman 2003</xref>]. Sporadic somatotropinomas or non-CNC- and non-MEN1-associated somatotropinomas do not appear to be frequently associated with <italic toggle="yes">PRKAR1A</italic> pathogenic variants [<xref ref-type="bibr" rid="carney.REF.sandrini.2002a.e78">Sandrini et al 2002a</xref>, <xref ref-type="bibr" rid="carney.REF.yamasaki.2003.464">Yamasaki et al 2003</xref>].</p>
        <p><bold>Schwannomas.</bold> CNC is the only genetic condition other than <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis type 1</related-object>, <related-object link-type="booklink" source-id="gene" document-id="nf2" document-type="chapter">neurofibromatosis type 2</related-object>, and isolated familial schwannomatosis (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/162091">162091</ext-link>) in which schwannomas occur.</p>
      </sec>
      <sec id="carney.Management">
        <title>Management</title>
        <sec id="carney.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Carney complex (CNC), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Imaging or biochemical screening for endocrine tumors for diagnostic purposes only</p>
            </list-item>
            <list-item>
              <p>Thyroid ultrasonography, recommended as a satisfactory, cost-effective method for determining thyroid involvement in pediatric and young adults with CNC. Its value, however, is questionable in older individuals.</p>
            </list-item>
            <list-item>
              <p>In males, testicular ultrasonography at the initial evaluation</p>
            </list-item>
            <list-item>
              <p>In females, transabdominal ultrasonography during the first evaluation. Unless an abnormality is detected initially, the test need not be repeated because of the low risk for ovarian malignancy.</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="carney.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following interventions are routine:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cardiac myxoma.</bold> Open-heart surgery</p>
            </list-item>
            <list-item>
              <p><bold>Cutaneous and mammary myxoma.</bold> Surgical excision</p>
            </list-item>
            <list-item>
              <p><bold>Cushing syndrome.</bold> Bilateral adrenalectomy</p>
            </list-item>
            <list-item>
              <p><bold>Pituitary adenoma.</bold> Transsphenoidal surgery</p>
            </list-item>
            <list-item>
              <p><bold>Thyroid adenomas.</bold> Surgery if cancerous</p>
            </list-item>
            <list-item>
              <p><bold>LCCSCT.</bold> Orchiectomy usually required for boys with aggressively growing LCCSCT and gynecomastia to avoid premature epiphyseal fusion and induction of central precocious puberty. Tumors with lack of growth and mild gynecomastia can be treated medically with aromatase inhibitors.</p>
            </list-item>
            <list-item>
              <p><bold>PMS.</bold> Surgery to remove primary and/or metastatic lesions</p>
            </list-item>
          </list>
        </sec>
        <sec id="carney.Prevention_of_Primary_Manifestati">
          <title>Prevention of Primary Manifestations</title>
          <p>The only preventive measure in an asymptomatic individual is surgical removal of a heart tumor (cardiac myxoma) prior to the development of heart dysfunction, stroke, or other embolism.</p>
        </sec>
        <sec id="carney.Prevention_of_Secondary_Complicat">
          <title>Prevention of Secondary Complications</title>
          <p>Development of metabolic abnormalities from Cushing syndrome or arthropathy and other complications from acromegaly may be prevented by medical or surgical treatment of the respective endocrine manifestations.</p>
        </sec>
        <sec id="carney.Surveillance">
          <title>Surveillance</title>
          <p>Recommended clinical surveillance for individuals with CNC include the following:</p>
          <p>
            <bold>Pre-pubertal pediatric individuals</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Echocardiogram (annually; biannually for those with a history of excised myxoma)</p>
            </list-item>
            <list-item>
              <p>Testicular ultrasound for boys; close monitoring of growth rate and pubertal staging (annually)</p>
            </list-item>
          </list>
          <p>
            <bold>Post-pubertal pediatric and adult individuals</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Echocardiogram (annually or biannually for adolescent individuals with a history of excised myxoma)</p>
            </list-item>
            <list-item>
              <p>Testicular ultrasound (annually)</p>
            </list-item>
            <list-item>
              <p>Thyroid ultrasound (baseline examination; may be repeated as needed)</p>
            </list-item>
            <list-item>
              <p>Transabdominal ultrasound of the ovaries (baseline examination; may be repeated as needed)</p>
            </list-item>
            <list-item>
              <p>Urinary free cortisol levels (annually)</p>
            </list-item>
            <list-item>
              <p>Serum IGF-1 levels (annually)</p>
            </list-item>
          </list>
          <p>
            <bold>Further evaluation of affected individuals of all age groups, as needed</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>For primary pigmented nodular adrenocortical disease, in addition to urinary free cortisol levels:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Diurnal cortisol levels (11:30 pm, 12:00 am and 7:30 am, 8:00 am sampling)</p>
                </list-item>
                <list-item>
                  <p>Dexamethasone-stimulation test (modified Liddle&#x02019;s test, as per <xref ref-type="bibr" rid="carney.REF.stratakis.1999.585">Stratakis et al [1999]</xref>)</p>
                </list-item>
                <list-item>
                  <p>Adrenal computed tomography</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>For gigantism/acromegaly, in addition to serum IGF-1 levels:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Pituitary MRI</p>
                </list-item>
                <list-item>
                  <p>Three-hour oral glucose tolerance test (oGTT)</p>
                </list-item>
                <list-item>
                  <p>90-minute thyroid releasing hormone (TRH) testing</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>For psammomatous melanotic schwannoma: MRI (brain, spine, chest, abdomen, retroperitoneum, pelvis)</p>
            </list-item>
          </list>
        </sec>
        <sec id="carney.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures (see <xref ref-type="sec" rid="carney.Evaluations_Following_Initial_Dia">Evaluations Following Initial Diagnosis</xref> and <xref ref-type="sec" rid="carney.Surveillance">Surveillance</xref>).</p>
          <p>If the <italic toggle="yes">PRKAR1A</italic> pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
          <p>See <xref ref-type="sec" rid="carney.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="carney.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="carney.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="carney.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Carney complex (CNC) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="carney.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 70% of individuals diagnosed with CNC have an affected parent.</p>
            </list-item>
            <list-item>
              <p>Approximately 20% of individuals have CNC as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">PRKAR1A</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include elicitation of pertinent family history, physical examination for evidence of cutaneous pigmented spots and/or lumps and for signs of endocrine disease, and imaging and/or biochemical screening. If a pathogenic variant in <italic toggle="yes">PRKAR1A</italic> has been identified in the proband, molecular genetic testing of the parents should be considered.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with CNC may appear to be negative because of failure to recognize the disorder in family members or early death of the parent before the onset of symptoms. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations and molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents: if a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>In the absence of known family history, the risk to sibs of the proband is less than 1%.</p>
            </list-item>
            <list-item>
              <p>Germline mosaicism has not been observed in individuals with CNC.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with CNC has a 50% chance of inheriting the <italic toggle="yes">PRKAR1A</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Fertility may be impaired in males with CNC.</p>
            </list-item>
            <list-item>
              <p>It is possible that pregnancies in which a <italic toggle="yes">PRKAR1A</italic>-inactivating variant is present are more likely to end in spontaneous abortion; however, no data are yet available.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband. T</bold>he risk to the other family members depends on the status of the proband's parents: if a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="carney.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing at-risk asymptomatic adults and children.</bold> Consideration of molecular genetic testing of young at-risk family members is appropriate for guiding medical management (see Management, <xref ref-type="sec" rid="carney.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref>).</p>
          <p>When a clinically diagnosed relative has undergone molecular genetic testing and is found to have a pathogenic variant in <italic toggle="yes">PRKAR1A</italic>, molecular genetic testing can be used with certainty to clarify the genetic status of at-risk family members.</p>
          <p>When a clinically diagnosed relative is not available for testing, the use of molecular genetic testing for determining the genetic status of at-risk relatives is problematic, and test results need to be interpreted with caution.</p>
          <list list-type="bullet">
            <list-item>
              <p>Identification of a <italic toggle="yes">PRKAR1A</italic> pathogenic variant in an at-risk family member indicates that the same molecular genetic testing method can be used to assess the genetic status of other at-risk family members.</p>
            </list-item>
            <list-item>
              <p>Failure to identify a pathogenic variant in an at-risk family member does not eliminate the possibility that a <italic toggle="yes">PRKAR1A</italic> pathogenic variant is present; such individuals need to follow the recommendations for clinical surveillance of at-risk family members.</p>
            </list-item>
          </list>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with CNC has the pathogenic variant or clinical evidence of the disorder, the <italic toggle="yes">PRKAR1A</italic> pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="carney.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gene/5573"><italic toggle="yes">PRKAR1A</italic></ext-link> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for CNC are possible.</p>
          <p>Requests for prenatal testing for conditions which (like CNC) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Fetal ultrasound examination.</bold> A fetal heart tumor detected prenatally by ultrasound examination in an at-risk fetus may suggest the diagnosis; however, absence of such prenatal ultrasound findings does not rule out the diagnosis.</p>
        </sec>
      </sec>
      <sec id="carney.Resources">
        <title>Resources</title>
      </sec>
      <sec id="carney.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="carney.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">PRKAR1A</italic> appears to function as a classic tumor suppressor gene in tumors from individuals with Carney complex (CNC) as suggested by loss of heterozygosity (LOH) studies. Indeed, LOH was essential in identifying <italic toggle="yes">PRKAR1A</italic> as the causal gene in the families whose CNC phenotype mapped to 17q22-24 [<xref ref-type="bibr" rid="carney.REF.kirschner.2000a.89">Kirschner et al 2000a</xref>]. Subsequent studies, however, have shown that demonstrating LOH can be difficult because of significant admixture of tumor cells with normal cells in the mostly benign, hyperplastic tissue that either surrounds tumors (as is the case in the pituitary and adrenal glands) or in the primary lesion in CNC [Stratakis, unpublished data]. As expected, in some tumors LOH is not detected [<xref ref-type="bibr" rid="carney.REF.bertherat.2003.5308">Bertherat et al 2003</xref>, <xref ref-type="bibr" rid="carney.REF.tsilou.2004.395">Tsilou et al 2004</xref>]. Recently, a murine model of CNC was reported [<xref ref-type="bibr" rid="carney.REF.griffin.2004a.8811">Griffin et al 2004a</xref>]; LOH was not a consistent feature in the murine tumors [<xref ref-type="bibr" rid="carney.REF.griffin.2004b.923">Griffin et al 2004b</xref>].</p>
          <p>It has been demonstrated at both the protein and mRNA levels that <italic toggle="yes">PRKAR1A</italic> alleles with either nonsense or frameshift alterations are functionally null [<xref ref-type="bibr" rid="carney.REF.kirschner.2000a.89">Kirschner et al 2000a</xref>, <xref ref-type="bibr" rid="carney.REF.kirschner.2000b.3037">Kirschner et al 2000b</xref>, <xref ref-type="bibr" rid="carney.REF.groussin.2002.1433">Groussin et al 2002</xref>], indicating that loss of one allele of <italic toggle="yes">PRKAR1A</italic> is key in disease pathogenesis. The mRNA of such alleles is degraded selectively, a phenomenon known as nonsense-mediated mRNA decay. In tumors of individuals affected with CNC, biallelic inactivation of leads to enhanced intracellular signaling by protein kinase A (PKA), as evidenced by an almost twofold greater response to cAMP in CNC tumors than in non-CNC tumors [<xref ref-type="bibr" rid="carney.REF.groussin.2002.1433">Groussin et al 2002</xref>]</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">PRKAR1A</italic> has a genomic length of approximately 21 kb. The longest transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=47132582">NM_212472.1</ext-link> is composed of 11 exons; codon 1 is non-coding. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="carney" object-id="carney.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> A total of 125 different <italic toggle="yes">PRKAR1A</italic> pathogenic variants have been identified (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://prkar1a.nichd.nih.gov/"><italic toggle="yes">PRKAR1A</italic> Mutation Database</ext-link>) in 401 unrelated families of diverse ethnic origin; they are summarized in <xref ref-type="table" rid="carney.T.prkar1a_pathogenic_variants_dis">Table 2</xref> [<xref ref-type="bibr" rid="carney.REF.horvath.2010.369">Horvath et al 2010</xref>]. The molecular changes involve single base substitutions and small (&#x02264;15 bp) deletions, insertions, or combined rearrangements that are spread along the whole open reading frame (ORF) of the gene; in addition, several relatively large deletions have been reported [<xref ref-type="bibr" rid="carney.REF.horvath.2008.388">Horvath et al 2008</xref>, <xref ref-type="bibr" rid="carney.REF.salpea.2014.e183">Salpea et al 2014</xref>]. The pathogenic variants in <italic toggle="yes">PRKAR1A</italic> are spread along the whole coding sequence, without preference for an exon or a domain. Most of them are unique &#x02013; identified in single families [<xref ref-type="bibr" rid="carney.REF.bertherat.2009.2085">Bertherat et al 2009</xref>]. To date, only three pathogenic variants have been found in more than three unrelated pedigrees: c.82C&#x0003e;T, c.491_492delTG, and c.709-2_709-7 delATTTTT; these pathogenic variants occurred in kindreds with different racial and ethnic backgrounds, suggesting that they are likely to result from more than one independent mutation event. Allelotyping of several families for at least the c.491_492delTG and c.709-2_709-7 delATTTTT pathogenic variants confirmed that these pathogenic variants arose <italic toggle="yes">de novo</italic> in what appear to be &#x02018;&#x02018;hot spots&#x02019;&#x02019; for sequence changes in <italic toggle="yes">PRKAR1A</italic> [<xref ref-type="bibr" rid="carney.REF.kirschner.2000a.89">Kirschner et al 2000a</xref>, <xref ref-type="bibr" rid="carney.REF.groussin.2006.1943">Groussin et al 2006</xref>].</p>
          <table-wrap id="carney.T.prkar1a_pathogenic_variants_dis" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">PRKAR1A</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1"># of<break/>Alleles</th>
                  <th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference<break/>Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1A&#x0003e;G&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1Val</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_4" rowspan="29" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=47132582">NM_212472.1</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=47132583">NP_997637.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.82C&#x0003e;T&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln28Ter</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.109C&#x0003e;T&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln37Ter</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.124C&#x0003e;T&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.286C&#x0003e;T&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg96Ter</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.682C&#x0003e;T&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg227Ter</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">9</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.786_787delGGinsCT&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp262CysfsTer2</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.638C&#x0003e;A&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala213Asp</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">8</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.85_95del11&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala29ArgfsTer12</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.101_105del5&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser34CysfsTer9</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.139delA&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met46TrpfsTer82</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.177+3A&#x0003e;G</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.491_492delTG&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val164ArgfsTer5</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">38</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.530delTTAT&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val117fs26Ter</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.566_567delAAinsCAC&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu188AlafsTer44</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.693insT&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg232Ter</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.712insAA&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser238LysfsTer4</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.846insA&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val282SerfsTer9</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.178-2A&#x0003e;G&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.348+1G&#x0003e;C&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.550-2_550-9delATTTCACG&#x000a0;<sup>2</sup><break/>(c.550(-9-2)del8)</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.708+1G&#x0003e;T&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.709-2_709-7delATTTTT&#x000a0;<sup>7</sup><break/>(c.709(-7-2)del6)</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.891+3A&#x0003e;G&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.178_348del171&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Whole-gene deletion&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Exon 1 deletion&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Exon 2 deletion&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
                <tr>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Exon 9-11 deletion&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="carney.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="carney.TF.2.2">
                <label>2. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.kirschner.2000a.89">Kirschner et al [2000a]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.3">
                <label>3. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.cazabat.2006.211">Cazabat et al [2006]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.urban.2007.247">Urban et al [2007]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.perdig_o.2005.204">Perdig&#x000e3;o et al [2005]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.imai.2005.994">Imai et al [2005]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.groussin.2006.1943">Groussin et al [2006]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.horvath.2008.388">Horvath et al [2008]</xref>
                </p>
              </fn>
              <fn id="carney.TF.2.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="carney.REF.salpea.2014.e183">Salpea et al [2014]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The PRKAR1A protein consists of 381 amino acid residues organized in a dimerization/docking domain at the amino terminus, followed by a PKA inhibitor site, two tandem binding domains for cAMP at the carboxyl terminus (cAMP:A and cAMP:B), and a linker region that contains the main docking site for the C subunit [<xref ref-type="bibr" rid="carney.REF.zawadzki.2004.7029">Zawadzki &#x00026; Taylor 2004</xref>].</p>
          <p><bold>Abnormal gene product.</bold> The majority of pathogenic variants (&#x0003e;80%) predict or result in creation of a premature stop codon by nonsense, frameshift, or splicing changes upstream of the last exon. Such variants predict degradation of the mutant mRNAs through a mechanism of nonsense-mediated decay (NMD). A relatively small proportion of pathogenic variants result in the expression of an altered protein; this group comprises missense substitutions, frameshift variants affecting the last exon of the gene (and thus escaping NMD), in-frame deletions, and one splice variant that leads to an in-frame change (c.177+3A&#x0003e;G).</p>
          <sec id="carney.Cancer_and_Benign_Tumors">
            <title>Cancer and Benign Tumors</title>
            <p><italic toggle="yes">PRKACA</italic> somatic pathogenic variants have been detected in 37% of unilateral adenomas from individuals with overt Cushing&#x02019;s syndrome [<xref ref-type="bibr" rid="carney.REF.beuschlein.2014.1019">Beuschlein et al 2014</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="carney.References">
        <title>References</title>
        <sec id="carney.Published_GuidelinesConsensus_Sta">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="carney.Published_GuidelinesConsensus_Sta.reflist0">
            <ref id="carney.REF1">
              <mixed-citation publication-type="web">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://jco.ascopubs.org/content/28/5/893.long">online</ext-link>; registration or institutional access required. 2010. Accessed 3-2-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="carney.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="carney.Literature_Cited.reflist0">
            <ref id="carney.REF.bertherat.2009.2085">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazabat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Libe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren&#x000e9;-Corail</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourdeau</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bei</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calender</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>94</volume>
                <fpage>2085</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19293268</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.bertherat.2003.5308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandrini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bei</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papageorgiou</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourdeau</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent-Dejean</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlemoine</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gicquel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.</article-title>
                <source>Cancer Res</source>
                <volume>63</volume>
                <fpage>5308</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">14500362</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.beuschlein.2014.1019">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beuschlein</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassnacht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assi&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calebiro</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osswald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieland</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sbiera</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faucz</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmittfull</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarzmayr</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barreau</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzosi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizk-Rabin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szarek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salpea</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kisker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diener</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohse</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reincke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allolio</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.</article-title>
                <source>N Engl J Med.</source>
                <volume>370</volume>
                <fpage>1019</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">24571724</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.cazabat.2007.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cazabat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lib&#x000e8;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlemoine</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren&#x000e9;-Corail</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burnichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimenez-Roqueplo</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupasquier-Fediaevsky</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raffin-Sanson</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.</article-title>
                <source>Eur J Endocrinol</source>
                <volume>157</volume>
                <fpage>1</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17609395</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.cazabat.2006.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cazabat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragazzon</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>PRKAR1A mutations in primary pigmented nodular adrenocortical disease.</article-title>
                <source>Pituitary</source>
                <volume>9</volume>
                <fpage>211</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17036196</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.fogt.2002.59">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fogt</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narula</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Genetic alterations of Carney complex are not present in sporadic cardiac myxomas.</article-title>
                <source>Int J Mol Med</source>
                <volume>9</volume>
                <fpage>59</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11744997</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.forlino.2014.1065">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garavelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccone</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>London</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O.N</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>PRKACB and Carney complex.</article-title>
                <source>N Engl J Med.</source>
                <volume>370</volume>
                <fpage>1065</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24571725</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.frohman.2003.165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frohman</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Isolated familial somatotropinomas: clinical and genetic considerations.</article-title>
                <source>Trans Am Clin Climatol Assoc</source>
                <volume>114</volume>
                <fpage>165</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">12813918</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.griffin.2004a.8811">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson-White</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenherr</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinberg</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claflin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meoli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho-Chung</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.</article-title>
                <source>Cancer Res</source>
                <volume>64</volume>
                <fpage>8811</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15604237</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.griffin.2004b.923">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson-White</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenherr</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinberg</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claflin</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batista</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourdeau</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voutetakis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandrini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meoli</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho-Chung</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornstein</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2004b</year>
                <article-title>A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>923</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15591278</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.groussin.2006.1943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jullian</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rene-Corail</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefebvre</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cephise-Velayoudom</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vantyghem</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conte-Devolx</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentil</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malchoff</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tissier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>91</volume>
                <fpage>1943</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16464939</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.groussin.2002.1433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent-Dejean</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlemoine</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jullian</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delemer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zacharieva</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pignatelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luton</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>1433</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12424709</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.horvath.2010.369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillaud-Bataille</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazabat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lib&#x000e9;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remmers</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ren&#x000e9;-Corail</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faucz</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calender</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.</article-title>
                <source>Hum Mutat</source>
                <volume>31</volume>
                <fpage>369</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">20358582</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.horvath.2006.794">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giatzakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson-White</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffin</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delimpasi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsiao</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keil</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heyerdahl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Libe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fratticci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cramer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaillard</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bossis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.</article-title>
                <source>Nat Genet</source>
                <volume>38</volume>
                <fpage>794</fpage>
                <lpage>800</lpage>
                <pub-id pub-id-type="pmid">16767104</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.horvath.2008.388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bossis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giatzakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meoli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson-White</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remmers</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nesterova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Large deletions of the PRKAR1A gene in Carney complex.</article-title>
                <source>Clin Cancer Res</source>
                <volume>14</volume>
                <fpage>388</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">18223213</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.imai.2005.994">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taketani</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maemura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nojiri</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawanami</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monzen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murakawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takamoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic analysis in a patient with recurrent cardiac myxoma and endocrinopathy.</article-title>
                <source>Circ J</source>
                <volume>69</volume>
                <fpage>994</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16041174</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.kirschner.2000a.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pack</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taymans</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giatzakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho-Chung</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>89</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">10973256</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.kirschner.2000b.3037">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandrini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monbo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>3037</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">11115848</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.kjellman.2001.948">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kjellman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backdahl</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Genetic background of adrenocortical tumor development.</article-title>
                <source>World J Surg</source>
                <volume>25</volume>
                <fpage>948</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">11572037</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.mateus.2008.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mateus</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palangi&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franck</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertagna</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avril</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupin</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Heterogeneity of skin manifestations in patients with Carney complex.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>59</volume>
                <fpage>801</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">18804312</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.perdig_o.2005.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perdig&#x000e3;o</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stergiopoulos</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Marco</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimenta</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas.</article-title>
                <source>Genes Chromosomes Cancer</source>
                <volume>44</volume>
                <fpage>204</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16001434</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.salpea.2014.e183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salpea</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>London</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faucz</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gourgari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dauber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keil</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyssikatos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanidad</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dai</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mowrey</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>99</volume>
                <fpage>E183</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24170103</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.sandrini.2002a.e78">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sandrini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bei</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmakidis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasufuku-Takano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takano</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prezant</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marx</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groussin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>e78</fpage>
                <pub-id pub-id-type="pmid">12471216</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.sandrini.2002b.182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sandrini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyakhina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarlis</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farmakidis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gimm</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.</article-title>
                <source>Genes Chromosomes Cancer</source>
                <volume>35</volume>
                <fpage>182</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12203783</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.stratakis.2004.2556">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertherat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutation of perinatal myosin heavy chain.</article-title>
                <source>N Engl J Med</source>
                <volume>351</volume>
                <fpage>2556</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15590965</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.stratakis.1996.699">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanicolaou</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karl</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kastner</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pras</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrousos</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2.</article-title>
                <source>J Clin Invest.</source>
                <volume>97</volume>
                <fpage>699</fpage>
                <lpage>705</lpage>
                <pub-id pub-id-type="pmid">8609225</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.stratakis.2000.4920">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Isolated familial somatotropinomas: does the disease map to 11q13 or to 2p16?</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>85</volume>
                <fpage>4920</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">11134164</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.stratakis.2000.4359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papageorgiou</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Premkumar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pack</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taymans</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhuang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oelkers</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>85</volume>
                <fpage>4359</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">11095480</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.stratakis.1999.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarlis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doppman</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nieman</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrousos</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papanicolaou</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.</article-title>
                <source>Ann Intern Med.</source>
                <volume>131</volume>
                <fpage>585</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">10523219</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.tsilou.2004.395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsilou</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandrini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaiser-Kupfer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Eyelid myxoma in Carney complex without PRKAR1A allelic loss.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>130A</volume>
                <fpage>395</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15368482</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.urban.2007.247">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinhausel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritsch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sovinz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinhandl</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lackner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moritz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>OA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Primary pigmented nodular adrenocortical disease (PPNAD) and pituitary adenoma in a boy with sporadic Carney complex due to a novel, de novo paternal PRKAR1A mutation (R96X).</article-title>
                <source>J Pediatr Endocrinol Metab</source>
                <volume>20</volume>
                <fpage>247</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">17396442</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.veugelers.2004.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Veugelers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDermott</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weremowicz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mabry</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefaivre</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zunamon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Destree</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaudron</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basson</surname>
                    <given-names>CT</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutation of perinatal myosin heavy chain associated with a Carney complex variant.</article-title>
                <source>N Engl J Med</source>
                <volume>351</volume>
                <fpage>460</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15282353</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.watson.2000.413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watson</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryant-Greenwood</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfield</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Neurosurgical implications of Carney complex.</article-title>
                <source>J Neurosurg</source>
                <volume>92</volume>
                <fpage>413</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10701527</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.yamasaki.2003.464">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizusawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagahiro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itakura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimoto</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <volume>58</volume>
                <fpage>464</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12641630</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.zawadzki.2004.7029">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zawadzki</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP.</article-title>
                <source>J Biol Chem.</source>
                <volume>279</volume>
                <fpage>7029</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">14625280</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="carney.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="carney.Suggested_Reading.reflist0">
            <ref id="carney.REF.boikos.2006.189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Carney complex: pathology and molecular genetics.</article-title>
                <source>Neuroendocrinology</source>
                <volume>83</volume>
                <fpage>189</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">17047382</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.pereira.2010.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hes</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woortman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greene</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bimpaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alatsatianos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boikos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smit</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romijn</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nesterova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>95</volume>
                <fpage>338</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19915019</pub-id>
              </element-citation>
            </ref>
            <ref id="carney.REF.stratakis.2004">
              <mixed-citation publication-type="web">Stratakis CA, Matyakhina L. Carney complex (CNC). <italic toggle="yes">Atlas of Genetics and Cytogenetics in Oncology and Haematology</italic>. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://atlasgeneticsoncology.org/Kprones/CarneyComplexID10080.html">online</ext-link>. 2004. Accessed 3-2-17.</mixed-citation>
            </ref>
            <ref id="carney.REF.veugelers">
              <mixed-citation publication-type="web">Veugelers M, Vaughan CJ, Basson CT. Familial cardiac myxomas and Carney complex. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 46. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. Accessed 3-2-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="carney.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="carney.Author_Notes">
          <title>Author Notes</title>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dir.nichd.nih.gov/dirweb/affiliationDetail.html?x=vqJ%3E%3D%403np%22v%7C%7BJtr%22Nssvyvn%22v%7C%7BQr%22nvy&#x00026;g=3ea4d7b993ae6e6d80c8f89e7753e659">Section on Endocrinology and Genetics</ext-link>
          </p>
        </sec>
        <sec id="carney.Author_History">
          <title>Author History</title>
          <p>Anelia Horvath, PhD; National Institutes of Health (2003-2015)Margarita Raygada, MSc, PhD (2015-present)Paraskevi Salpea, PhD (2015-present)Constantine A Stratakis, MD, DSc (2003-present)</p>
        </sec>
        <sec id="carney.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 September 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 June 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 January 2008 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>22 March 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 February 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>7 October 2002 (cs) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Carney Complex&#x02019; is in the public domain in the United States of America.</p>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
